Patented drug tariffs: India more or less shielded, says GTRI
U.S. President Trump signed an executive order, announcing the imposition of a 100% ad valorem duty on the import of certain patented pharmaceuticals and associated pharmaceutical ingredients
What's Your Reaction?
